References
- Aguiar J, Carpena P, Molina-Bolivar JA, et al. (2003). On the determination of the critical micelle concentration by the pyrene 1: 3 ratio method. J Colloid Interface Sci 258:116–22
- Chitkara D, Kumar N. (2013). BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs. Pharm Res 30:2396–409
- Gelderblom H, Loos WJ, Verweij J, et al. (2002). Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies. Eur J Cancer 38:205–13
- Gill IJ, Illum L, Farraj N, et al. (1994). Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane. Eur J Pharm Sci 1:237–48
- Janos S, Franco MM, Carl RA. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90:300–6
- Li L, Kim JK, Huh KM, et al. (2012). Targeted delivery of paclitaxel using folate-conjugated heparin-poly (β-benzyl-l-aspartate) self-assembled nanoparticles. CarbohydrPolym 87:2120–8
- Liggins RT, Burt HM. (2002). Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 54:191–202
- Lo CL, Huang CK, Lin KM, et al. (2007). Mixed micelles formed from graft and diblock copolymers for application in intracellular drug delivery. Biomaterials 28:1225–35
- Naal RM, Tabb J, Holowka D, Baird B. (2004). In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells. Biosens Bioelectron 20:791–6
- Qu D, Lin HJ, Zhang N, et al. (2013). In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. Carbohydr Polym 92:545–54
- Shan XQ, Yuan Y, Liu CS, et al. (2009). Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles. Biomedmicrodevices 11:1187–94
- Szebeni J. (2005). Complement activation-related pseudoallergycaused by amphiphilicdrug carriers: the role of lipoproteins. Curr Drug Deliv 2:443–9
- Wei Y, Wang YX, Wang W, et al. (2012). Microcosmic mechanisms for protein incomplete release and stability of various amphiphilic mPEG-PLA microspheres. Lxsangmuir 28:13984–92
- Zhang XC, Jackson JK, Burt HM. (1996). Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132:195–206
- Zhang XF, Li YX, Chen XS, et al. (2005). Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate. Biomaterials 26:2121–8
- Zheng XL, Kan B, Gou ML, et al. (2010). Preparation of MPEG–PLA nanoparticle for honokiol deliveryin vitro. Int J Pharm 386:262–7
- Zhang Y, Huo MR, Zhou JP, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–71
- Zhang ZS, Zhang QB, Wang J, et al. (2010). Synthesis and drug releasein vitroof porphyran carrying 5-Fluorouracil. Carbohydr Polym 79:628–32